MADAM NOVARTIS
Retrospective-prospective observational study of Italian patients treated in melanoma adjuvant [...]
STAR-121 GILEAD
A Randomized, Open-Label, Phase 3 Study to Evaluate Zimberelimab and [...]
KRYSTAL-12 MIRATI
A Randomized Phase 3 Study of MRTX849 versus Docetaxel in [...]
EVOKE GILEAD
Open-Label, Global, Multicenter, Randomized, Phase 3 Study of Sacituzumab Govitecan [...]
SAPPHIRE MIRATI
A Randomized Phase 3 Study of Sitravatinib in Combination with [...]
STARDUST
Phase II trial evaluating the efficacy of durvalumab (MEDI4736)as second-line [...]
OCRA
First-line Osimertinib plus Consolidation Radiotherapy compared with Osimertinib alone in [...]
RE-ALEC MO 42122 ROCHE
A multicenter non-interventional cohort study to evaluate the real- world [...]
B-FAST -BO29554
A phase II/III multicenter study evaluating the efficacy and safety [...]
M18-868 ABBVIE
Studio Clinico Globale, In Aperto, Randomizzato, Controllato, di Fase 3 [...]
